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Thiol-disulfide exchange between the PDI family of oxidoreductases
negates the requirement for an oxidase or reductase for each enzyme
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The formation of disulfides in proteins entering the secretory
pathway is catalysed by the protein disulfide isomerase
(PDI) family of enzymes. These enzymes catalyse the
introduction, reduction and isomerization of disulfides. To
function continuously they require an oxidase to reform the
disulfide at their active site. To determine how each family
member can be recycled to catalyse disulfide exchange, we have
studied whether disulfides are transferred between individual PDI
family members. We studied disulfide exchange either between
purified proteins or by identifying mixed disulfide formation
within cells grown in culture. We show that disulfide exchange
occurs efficiently and reversibly between specific PDIs. These
results have allowed us to define a hierarchy for members of the
PDI family, in terms of ability to act as electron acceptors or
donors during thiol-disulfide exchange reactions and indicate that
there is no kinetic barrier to the exchange of disulfides between
several PDI proteins. Such promiscuous disulfide exchange
negates the necessity for each enzyme to be oxidized by Ero1
(ER oxidoreductin 1) or reduced by a reductive system. The lack
of kinetic separation of the oxidative and reductive pathways in
mammalian cells contrasts sharply with the equivalent systems
for native disulfide formation within the bacterial periplasm.
Key words: disulfide formation, electron transfer, endoplasmic
reticulum, protein disulfide isomerase, redox potential,
thiol-disulfide exchange.
INTRODUCTION
A family of proteins, collectively termed the protein disulfide
isomerases (PDIs), is responsible for formation of correct
disulfides in proteins entering the secretory pathway. This protein
family is characterized by the presence of one or more domains
structurally related to thioredoxin (Figure 1). Most members
of the family contain a redox active CXXC motif; exceptions
include endoplasmic reticulum (ER)p27 and ERp29 [1,2]. The
relative orientation of the thioredoxin domains and their active
site chemistries vary depending on the particular enzyme and
may determine the specific functions of each protein [3,4].
As oxidoreductases, PDI proteins typically catalyse thiol-
disulfide exchange reactions. Consequently, whether these
enzymes function in the formation or breaking of a disulfide
depends on the reduction potential of their CXXC active site
disulfide, their ability to be recycled efficiently and their functional
interaction with their substrate proteins [5,6]. For efficient
introduction of disulfide bonds into substrates a robust pathway of
oxidation of the PDI disulfide must exist. To reduce disulfides the
active site disulfide needs to be itself reduced. These requirements
emphasize the need for machineries within the ER to cater for both
oxidation and reduction in PDI protein active sites.
A number of processes that oxidize PDI proteins have
been characterized which require enzymes such as Ero1
(ER oxidoreductin 1), PrxIV (peroxiredoxin IV), glutathione
peroxidase (Gpx7/8) and VKOR (vitamin K epoxide reductase)
[7–10]. The Ero1 pathway is the most conserved and generally
accepted to be the predominant oxidative pathway. Mammals
contain two isoforms of Ero1 (Ero1α and Ero1β), which utilize
the oxidizing power of molecular oxygen to generate a disulfide
bond, producing hydrogen peroxide as a by-product [11–13].
The Ero1 enzymes preferentially oxidize active site thiols within
the archetypal PDI with lesser activity towards ERp46 and
little activity towards other PDI proteins [14,15]. The PrxIV
pathway also shows selectivity towards specific PDI proteins.
Most notably preference exists towards P5 and ERp46 with other
PDI proteins being poorly oxidized [16]. Although no direct
evidence for VKOR substrate specificity exists, it is known that
only ERp18 and some of the thioredoxin-like transmembrane
(TMX), membrane-bound PDI proteins, seem to be able to form
mixed disulfides with VKOR [17]. Mixed disulfide formation
indicates that these PDI proteins are able to reduce a disulfide
within VKOR suggesting that they may also be selectively
oxidized. The selectivity of these oxidative pathways suggests
that a mechanism must exist to oxidize the other PDI proteins that
partake in the introduction of disulfides into client proteins.
Whereas substantial progress has been made to understand how
PDI proteins are oxidized, no enzyme-catalysed pathway for their
reduction has been characterized to date. The necessity to reduce
disulfides, both non-native and native, by PDI proteins is crucial
during folding of complex disulfide-containing polypeptides,
during ER-associated degradation (ERAD) and in the regulation
of the unfolded protein response (UPR) [18–20]. The consequence
of this reduction is that the PDI proteins will be oxidized requiring
a reductive pathway to recycle the enzyme for further activity.
One particular PDI protein, ERdj5, is required for reduction in
disulfides prior to ERAD or correct folding [18,19]. Previously,
it was suggested that cytosol-derived glutathione could be the
reductant [21,22] required to recycle selected PDI proteins with
reducing activity. Depletion of glutathione increases the formation
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Figure 1 Schematic diagram showing the various PDI proteins in the
present study
The schematic depicts the domain organizations of various PDI proteins. The active sites are
shown to indicate the variation in amino acid sequence between the cysteine residues. The
domains a, b, b’ and a’ for PDI and ERp57 are indicated as well as the four redox active
thioredoxin domains and J domain of ERdj5.
of non-native disulfides in proteins [23]; however, the rate
of formation of native disulfides appeared unaffected [23,24],
suggesting that glutathione is dispensable for native disulfide
formation. This suggests the existence of a yet to be identified
pathway for selective reduction in PDI proteins such as ERdj5.
In an attempt to extend our understanding of how individual
PDI family members are oxidized or reduced, we have examined
the ability of various PDI proteins to exchange disulfides with
one another. Using enzyme assays with purified, recombinant PDI
proteins, we demonstrate that several PDI proteins can interact and
exchange disulfides. In addition, the formation of mixed disulfide
complexes in stable cell lines reveals that PDI proteins can react
with each other within a cellular context. These results suggest the
existence of a disulfide exchange cascade that transfers oxidizing
equivalents between individual PDI proteins. Such ready transfer
of disulfides between individual PDI proteins contrasts with the
situation within the bacterial periplasm where the oxidative and
reductive pathways are kinetically separated with little or no cross-
talk between the disulfide exchange proteins involved in disulfide
formation or reduction [25].
EXPERIMENTAL
Antibodies and reagents
The following mouse monoclonal antibodies were used: anti-V5
(Invitrogen), anti-V5-conjugated agarose beads (Sigma–Aldrich),
anti-His (GE Healthcare) and anti-GAPDH (glyceraldehyde-
3-phosphate dehydrogenase; Ambion). The rabbit polyclonal
antisera raised against P5, PDI and ERp57 have been described
previously [26]. N-ethylmaleimide (NEM) and 4-acetamido-4′-
maleimidylstilbene-2,2′-disulfonic acid (AMS) were purchased
from Sigma and Life technologies respectively.
Cell culture
HT1080 cell lines were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 4.5 g/l glucose,
10% FBS and 0.56 mM L-glutamine. Stable cell lines expressing
the substrate-trap mutants (CXXA) of the PDI oxidoreductases
have been described previously [18,26].
Recombinant protein expression and purification
The expression and purification of thioredoxin, wild-type (wt)
PDI, P5 and ERp57 have been described previously [8,27]. PDI
S1S2 (a gift from Professor Lloyd Ruddock, Oulu Finland), in
which both active sites are mutated to AGHA, was expressed and
purified as described for the wt protein. Both ERp72 and ERp46
were expressed as GST-fusion proteins (pGEX-6P-1) as described
[28] and purified on a 5 ml of GSTrap HP column (GE Healthcare)
pre-equilibrated with 50 mM Tris/HCl, pH 7.4, buffer containing
150 mM NaCl, 1 mM EDTA and 1 mM DTT. GST-tagged proteins
were eluted by the application of a linear gradient of 0–10 mM
GSH (over five column volumes at a flow rate of 2 ml/min)
in 50 mM Tris/HCl, pH 7.4, buffer containing 150 mM NaCl,
1 mM EDTA, 1 mM DTT and 10 mM GSH. PreScission Protease
(Amersham Pharmacia) digestion of the GST-tagged recombinant
proteins was carried out according to the manufacturer’s protocol,
to obtain ERp72 and ERp46. Isolated ERp72 and ERp46 were
further purified by gel filtration using a 120 ml of Superdex 75
16/60 prep-grade column (Amersham Pharmacia) on an AKTA
purifier system (GE Healthcare), in 50 mM Tris/HCl, pH 7.5,
buffer containing 150 mM NaCl and1 mM EDTA.
Reduction and oxidation of PDI proteins
PDI proteins were reduced with 10 mM DTT for 10 min at room
temperature. DTT was removed using a 5 ml of Hitrap desalt
column (GE Healthcare) pre-equilibrated with 50 mM Tris/HCl,
pH 7.5, buffer containing 150 mM NaCl and 1 mM EDTA (buffer
A), according to the manufacturer’s protocol. To oxidize the
proteins, samples were incubated with 10 mM GSSG for 10 min
at room temperature. GSSG was removed by gel filtration using
a Superdex 10/300 GL column (GE Healthcare) pre-equilibrated
with buffer A. The redox status of all PDI proteins was verified
by carrying out AMS alkylation and separation by SDS/PAGE.
Gel-based thiol-disulfide exchange reaction
To determine if the PDI protein can exchange disulfides,
equimolar amounts (typically 2 μM) of reduced and oxidized
recombinant PDI oxidoreductases were incubated in buffer A with
samples taken at specific time points. The reactions were stopped
by boiling in SDS sample buffer (200 mM Tris/HCl buffer, pH 6.8,
3%SDS, 10% glycerol, 1 mM EDTA and 0.004%Bromophenol
Blue) supplemented with 10 mM AMS to freeze the redox states.
Finally samples were analysed under non-reducing SDS/PAGE
followed by Coomassie staining or Western blotting to visualize
the redox states of the individual PDI proteins. Quantification of
band intensities was carried out using ImageJ software.
Immunoisolation and Western blots
Confluent HT1080 cells and HT1080 cells stably overexpressing
substrate-trapping PDI oxidoreductases were rinsed twice with
PBS supplemented with 20 mM NEM. Cells were lysed in
buffer containing 50 mM Tris/HCl, pH 7.4, 1% (v/v) Triton
X-100, 150 mM NaCl, 2 mM EDTA and 0.5 mM PMSF (lysis
buffer) supplemented with protease inhibitor cocktail (Roche).
Immunoisolation and SDS/PAGE were performed as described
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above. For Western blotting, proteins were transferred to
nitrocellulose membranes (LI-COR Biosciences), which were
blocked in either 5% (w/v) dried milk or 3% BSA (for ERp57
blots) in 10 mM Tris/HCl buffer, pH 7.5, containing 150 mM
NaCl and 0.1% (v/v) Tween 20 for 1 h. Blots were incubated
with primary antibody for 1 h at room temperature. LI-COR
IRDye fluorescent secondary antibodies were used for detection
at a 1:10000 dilution. Blots were scanned using an Odyssey Sa
Imaging System (LI-COR Biosciences).
Determination of in cellulo redox status of ER-localized thioredoxin
and ERdj5
Hela cells stably expressing doxycycline inducible human
thioredoxin, engineered with a V5-tag and KDEL ER-retrieval
sequence at the C-terminus, were generated using the Flp-In T-Rex
Core Kit (Invitrogen). The HT1080 cell line stably overexpressing
wt ERdj5 has been described previously [18]. The in cellulo redox
state of thioredoxin and ERdj5 with AMS were determined as
described previously [22].
RESULTS
Quantitative gel-based assay for disulfide exchange between PDI
proteins
Disulfide bond formation catalysed by the PDI proteins typically
involves a bimolecular nucleophilic substitution reaction (SN2)
initiated by the attack on a disulfide bond by a nucleophilic thiolate
anion. The reaction proceeds via a transient mixed-disulfide
intermediate which becomes resolved, resulting in the reduced
reactant becoming oxidized and the oxidized reactant becoming
reduced (Figure 2A). Such a reaction requires the participating
sulfur atoms to be in a linear orientation. To determine if the
active site thiols of the PDI proteins can exchange disulfides
with one another, we assayed their redox status following co-
incubation, by modification of free thiols with the alkylating
agent AMS. Alkylation by AMS results in a mass increase of
approximately 510 Da per modified thiol causing a decrease
in mobility of reduced proteins relative to oxidized proteins on
SDS/PAGE (Figure 2B). We elected to study ERp57 and ERp72 as
substrates in these experiments as both proteins produced the most
discernible gel shifts between the oxidized and reduced species,
which allowed for easy quantification and interpretation of the
results (Figure 2C). Stoichiometric amounts of reduced ERp57
and oxidized ERp72 were incubated together and their redox
status ascertained by AMS modification at various time points.
At the start of the reaction ERp57 and ERp72 were completely
reduced and oxidized respectively (lane 3). However, after 5 min
of incubation (lane 4), we see the appearance of a slow-migrating
form of ERp72, consistent with AMS modification and reduction.
The intensity of this slow-migrating ERp72 increases as time
progresses (lanes 5–7). Conversely, the reduced ERp57 becomes
oxidized by ERp72 in a time-dependent manner, typified by the
appearance of a fast-migrating, non-AMS modified form of
the protein. This result demonstrates disulfide exchange between
the two proteins and suggests that the active site thiols are able
to adopt the correct geometry to carry out the SN2 reaction.
The disulfide exchange is most likely to occur via the catalytic
disulfides as ERp72 does not contain any non-catalytic disulfides,
the non-catalytic disulfide in ERp57 is structural and buried in the
structure and we showed using a differential alkylation approach
followed by MS that the non-catalytic disulfide in ERp57 is not
reduced following treatment with 10 mM DTT demonstrating it
is solvent inaccessible (results not shown).
PDI proteins form a hierarchy for disulfide exchange
Having established that reduced ERp57 and oxidized ERp72
engage in disulfide exchange, we then examined if other PDI
proteins can exchange disulfides with ERp57 and ERp72. To
determine if various oxidized PDIs can accept electrons from
reduced forms of ERp57 and ERp72, stoichiometric amounts
of oxidized PDI proteins including ERp46, ERp18, P5, ERp72,
PDI wt and PDI S1S2 (both active sites mutated to AGHA)
were incubated with reduced ERp57 and ERp72 (Figure 3). We
included a PDI S1S2 mutant in these assays as a control to
demonstrate that any disulfide exchange observed with the wt PDI
could only be due to its active site disulfide. Representative results
from the incubation of either oxidized PDI or oxidized PDI S1S2
with reduced ERp57 are shown (Figure 3A). Quantitative Western
blotting was carried out rather than Coomassie Blue staining as
PDI has a similar mobility to ERp57. Reduced and oxidized
ERp57 controls are indicated in lanes 1 and 2 respectively. As
observed with ERp72 (Figure 2C), after 5 min of incubation with
PDI, a fast-migrating form of ERp57 appeared which increased in
intensity up to 60 min of incubation (lanes 3–7). This is consistent
with the oxidation of ERp57 by PDI. In contrast, reduced ERp57
incubated in assay buffer only for the entire duration of the time
course (lane 8) or with oxidized PDI S1S2 (Figure 3A, bottom
panel), was not oxidized, as demonstrated by the absence of the
fast-migrating form of the protein. These results demonstrate that
the oxidation of ERp57 is catalysed by PDI and that disulfide
exchange requires the PDI active sites disulfides. Similar results
were obtained when PDI was incubated with ERp72 (Figure 3B).
The result reveals a faster-migrating form of ERp72, only evident
upon incubation with wt PDI (top panel) but not with the active
sites mutant, PDI S1S2 (bottom panel).
The ability of other PDI proteins to exchange disulfides with
ERp57 and ERp72 was determined and the time courses of
oxidation quantified (Figures 3C and 3D). The results suggest
that the various PDI proteins exchange disulfides with ERp57 and
ERp72 to varying degrees. It should be noted that the ability
of each PDI to exchange disulfides will be dependent upon
several factors potentially including the number of catalytically
active disulfides in the donor and recipient (Figure 1). For
example, the oxidized ERp46 (three disulfides) was most efficient
in exchanging disulfides with reduced ERp57 (two disulfides;
Figure 3C) whereas ERp18 (1 disulfide) was relatively inefficient
(Figure 3C). Perhaps a better comparison is between PDI proteins
that have the same number of active site disulfides such as PDI and
P5. For ERp72, PDI oxidized the recipient active site disulfides
more rapidly and to a greater extent than P5 (Figures 3C and
3D). Strikingly, ERp18 only slowly exchanged disulfides with
ERp57 and was unable to exchange disulfides with reduced ERp72
(Figure 3D). Our results do not allow us to define which of
the thioredoxin domains within individual PDI proteins becomes
reduced or oxidized; however, they do allow us to conclude that
disulfide exchange is occurring. Taken together these results show
that there is a hierarchy of ability of PDI proteins able to exchange
active site disulfides, with PDI and ERp46 being the most and
ERp18 the least efficient.
Having established that various oxidized PDIs can exchange
disulfides with reduced forms of ERp57 and ERp72, we next
examined the possibility of electron transfer between reduced
PDI proteins and oxidized ERp72. An equivalent experiment
with ERp57 could not be performed due to the insolubility of
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
282 O.B.V. Oka, H.Y. Yeoh and N.J. Bulleid
Figure 2 Thiol-disulfide exchange reaction between ERp72 and ERp57
(A) Reversible thiol-disulfide exchange between PDI proteins and their substrates occurs through a mixed disulfide intermediate. This intermediate becomes resolved by the remaining thiolate in the
active site of the PDI if the overall reaction is the reduction in the substrate disulfide or by a second cysteine in the substrate if the exchange takes place in the reverse direction. The net result is the
exchange of a disulfide between PDI and substrate protein. O, oxidized; R, reduced. (B) Schematic figure depicting the gel-shift AMS-modification enzyme assay to investigate disulfide exchange.
Stoichiometric amounts (2 μM each) of reduced and oxidized recombinant PDI proteins were incubated in an endpoint time-course (step 1) for various times, samples were boiled in SDS/AMS
buffer to stop reaction (step 2). Samples were then separated on non-reducing SDS/PAGE and visualized by Coomassie staining or Western blotting (step 3). (C) Coomassie stained gel showing
disulfide exchange between reduced ERp57 and oxidized ERp72. The ERp57red, ERp72red and ERp57ox, ERp72ox indicate reduced and oxidized controls respectively.
the oxidized protein. Stoichiometric amounts of reduced PDIs
including ERp46, ERp18, P5, ERp57, PDI and PDI S1S2 were
incubated with oxidized ERp72 (Figure 4). A representative time
course with reduced PDI and reduced PDI S1S2 (Figure 4A)
demonstrates the reduction in ERp72 by reduced PDI but
not the active-site mutant protein. The results obtained from
assays involving oxidized ERp72 and reduced forms of PDI,
ERp46, ERp18, P5 and ERp57 indicate that several PDIs, to
varying degrees, can exchange disulfides with oxidized ERp72
(Figure 4B). PDI is the most efficient exchanger of disulfides with
reduced ERp72 with equilibrium being reached within 20 min. We
also noted that reduced ERp18 can transfer electrons to oxidized
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Figure 3 Oxidation of ERp57 and ERp72 by various PDI proteins
Disulfide exchange reactions between oxidized PDIs and reduced forms of ERp57 and ERp72 were carried out as described in Figure 2. (A) Representative blots showing the oxidation of reduced
ERp57 by PDI wt (top panel) and lack of oxidation by the active sites mutant, PDI S1S2 (bottom panel). Lane 8 is ERp57 incubated alone in buffer for 60 min. (B) Representative Coomassie stained
gels showing oxidation of ERp72 by wt PDI but not by active-sites mutant PDI or by dissolved oxygen in the assay buffer (lanes 8). Lane 1 and 2 contain reduced (red) and oxidized (ox) protein used
as controls. The percentages of ERp57 and ERp72 oxidized by the various PDIs was plotted as a function of time and shown in (C) and (D) respectively. The error bars represent +− S.D. for at least
three independent experiments.
ERp72 contrasting with the lack of disulfide exchange between
oxidized ERp18 and reduced ERp72.
Thioredoxin can efficiently donate electrons to PDI proteins
We have shown that various ER-localized PDIs, with similar
active site chemistries and redox potentials can engage in
disulfide exchange with varying efficiencies resulting in mixtures
of partially reduced and oxidized proteins. In particular, our
results show that PDI and ERp72 can engage in reversible
disulfide exchange; it did not matter which protein was reduced
or oxidized, disulfide exchange was still relatively efficient.
In order to examine to what extent the direction of disulfide
exchange can be driven by the reduction potential of the
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Figure 4 Reduction in oxidized ERp72 by various PDI proteins
Stoichiometric amounts of reduced PDIs and oxidized ERp72 were assayed as described in
Figure 2. (A) Representative Coomassie stained gels showing the reduction in oxidized ERp72
by PDI. Wt (top panel); PDI S1S2 (bottom panel). (B) The percentages of reduction in
ERp72 by the various PDI proteins were plotted against time. The error bars represent +− S.D.
for at least three independent experiments.
active-site disulfide, we assayed the ability of thioredoxin, a
cytosolic protein with a comparatively low redox potential (−270
mV) [29] to exchange disulfides with various PDI proteins. Ideally
we would have used ERdj5 for these experiments as it has the
lowest reduction potential of the PDI family [30] but unfortunately
we were unable to produce sufficient recombinant protein. When
reduced thioredoxin was incubated with a stoichiometric amount
of oxidized ERp72, PDI or ERp46 disulfide exchange was very
efficient (Figure 5A). Within 5 min of incubation, the thioredoxin
was completely oxidized, with corresponding reduction in the
PDI proteins. When included in excess, reduced thioredoxin
completely reduced ERp72 (Figure 5B). On the other hand,
no disulfide exchange occurred when oxidized thioredoxin was
incubated with reduced ERp57, ERp72 or ERp46 (Figure 5C).
This result demonstrates that the extent of disulfide exchange is
determined primarily by the reduction potential of the active-site
disulfide.
The ability of thioredoxin to efficiently reduce the PDI proteins
provided us with the opportunity to evaluate how efficient
the reductive pathway is within the ER at recycling oxidized
thioredoxin domains with low reduction potentials. Within the
bacterial periplasm, DsbC is maintained primarily in the reduced
state [31] by a robust reductive pathway involving the membrane
protein disulfide bond (DsbD) [32]. Thioredoxin is localized to
the cytosol where it is fully reduced. Hence, it would not normally
interact with the PDI proteins, but when thioredoxin was targeted
to the ER of mammalian cells by appending a signal sequence at
the N-terminus and a KDEL retrieval sequence at the C-terminus it
was fully oxidized (Figure 5D). Note that slower migrating bands
in this case indicate oxidized protein as free thiols are first blocked
with NEM and disulfides are subsequently reduced and then
alkylated with AMS. In addition, we observed that the primary
ER reductase ERdj5 was also fully oxidized in mammalian cells,
indicating that proteins containing thioredoxin domains with low
reduction potential are efficiently oxidized in the ER lumen. These
results contrast with the situation in the bacterial periplasm and
suggest that the reductive pathway in the ER is not kinetically
separated from the oxidative pathway.
The PDI proteins form mixed-disulfide complexes in cellulo
Thiol-disulfide exchange reactions typically involve the formation
of a transient mixed-disulfide intermediate between enzyme and
substrate, which is resolved to yield the final reaction products
(Figure 2A). Previous studies have shown that mutation of the PDI
CXXC active site motif to CXXA (cysteine to alanine) stabilizes
the mixed-disulfide intermediate formed between the enzyme and
substrate, allowing the identification of substrates for PDI proteins
[9,18,26,33].
To extend these studies, and in light of our observations that
various PDIs can exchange disulfides in vitro, we used the
substrate-trap approach to investigate if members of the PDI
family can form mixed-disulfides complexes with each other in
cells grown in culture. HT1080 stable cell lines overexpressing
V5-tagged CXXA mutants of PDI proteins were lysed in buffer
containing NEM to trap any mixed disulfides. The expression
of each PDI protein was verified by carrying out a V5-Western
blot (Figure 6A). When the cell lysates were analysed under non-
reducing SDS/PAGE, several V5-reactive high-molecular-mass
complexes were identified (Figures 6B and 6C, for ERp18). These
results demonstrate the presence of mixed disulfides between the
various PDI proteins and endogenous client proteins.
To determine the presence of other PDI proteins in the
mixed-disulfide complexes, we immunoisolated the exogenously
expressed PDI protein and separated the immunoisolated material
on reducing and non-reducing SDS/PAGE. Western blot analyses
were then carried out using antisera raised against specific
PDI proteins, including P5, PDI and ERp57 (Figures 6D–6F
respectively). To confirm that the interactions were specific to the
exogenously expressed PDI protein, untransfected HT1080 cell
lysates were immunoisolated as well and used as control. The anti-
P5 Western blots reveal extensive interactions between endogen-
ous P5 and other PDI proteins, notably ERp46, ERp18 and ERdj5.
Most of the immunoisolated P5 was not present as mixed-disulfide
complexes, suggesting that P5 forms non-covalent interactions
with some but not all PDI proteins. Mixed-disulfide complexes
were formed between P5 and ERdj5 (Figure 6D, top panel)
suggesting that disulfide exchange can occur between these two
PDI family members within a functionally intact ER. It is of
interest to note that P5 has been shown to reduce a disulfide in
the luminal domain of inositol-requiring enzyme 1 (IRE1) and in
the process regulate the UPR [20]. P5 will become oxidized in
the process so the formation of mixed disulfides between P5 and
ERdj5 might represent a mechanism to reduce and maintain P5 in
a state competent to interact with IRE1.
Western blots were also carried out to determine interactions
between the various PDI proteins and endogenous PDI
(Figure 6E). The result indicates that endogenous PDI forms
mixed disulfides with P5, ERp46, ERp18 and most notably ERdj5
(Figure 6E, top panel). Interestingly, we did not detect mixed
disulfides between PDI and the substrate-trapping mutants of
ERp57 and ERp72, despite the exchange of disulfides between
these proteins in our in vitro assays (Figure 3A and 3B).
Western blotting of immunoisolated material using anti-ERp57
also revealed most prominently an interaction with ERdj5
(Figure 6F). The non-reducing gel blot (top panel) shows
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Figure 5 Reduced thioredoxin rapidly exchanges disulfides with oxidized PDI proteins
His-tagged thioredoxin and various PDI proteins were incubated together and the extent of disulfide exchange assayed as described in Figure 2. (A) Reduced thioredoxin can efficiently transfer
electrons to oxidized PDI proteins. Left panel shows representative Western blots from reaction between stoichiometric amounts of ERp72 and thioredoxin; α-ERp72 (top) and α-His (bottom). The
middle and right panels include Coomassie stained gels for reactions involving reduced thioredoxin and oxidized PDI and ERp46 respectively. (B) Reduction in ERp72 when incubated with an
excess of thioredoxin (C) Representative Coomassie stained gels indicating no disulfide exchange when reduced PDI proteins are incubated with oxidized thioredoxin. Left, middle and right panels
indicate reactions between thioredoxin and ERp57, ERp72 and ERp46 respectively. (D) ER-localized thioredoxin and ERdj5 are predominantly oxidized at steady state. Hela cells stably expressing
doxycycline-inducible ER-localized V5-tagged thioredoxin and HT1080 cells overexpressing V5-tagged ERdj5 were either left untreated (UT) or treated with DTT (10 mM) or diamide (Dia; 5 mM) for
5 min. The samples were subjected to modification with AMS, followed by SDS/PAGE and anti-V5 blot.
extensive mixed-disulfide complexes between ERp57 and ERdj5.
The presence of multiple mixed disulfide species of ERdj5
with each of the PDI proteins tested indicates the ability to
form higher order structures stabilized by interchain disulfide
bonds.
DISCUSSION
In the present study, we demonstrate the ability of various purified
PDI proteins to exchange disulfides with each other and show that
similar exchange reactions can occur within mammalian cells.
It would appear that PDI and ERp46 are most likely to be the
conduits between Ero1 and the ER disulfide exchange proteins
and that ERdj5 is most likely to provide the conduit between
the ER disulfide exchange proteins and any putative reduction
pathway. Hence, the oxidative and reductive pathways in the ER
lumen need only interface with a restricted number of PDI proteins
to allow passage of electrons between most of the other members
of the family (Figure 7).
The fact that exchange reactions can occur relatively efficiently
raises the question of how the opposing pathways of disulfide
formation and reduction are regulated within the mammalian
secretory pathway. Within the bacterial periplasm, the two
pathways are kinetically segregated so that although the active
site reduction potentials of the disulfide exchange proteins DsbA
and DsbC are similar [34,35], DsbA is primarily oxidized and
catalyses the introduction of disulfides whereas DsbC is reduced
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Figure 6 PDI oxidoreductases form mixed-disulfide complexes
Cell lysates from HT1080 cells, either untransfected (UT) or stably expressing the V5-tagged substrate-trapping mutants of the PDI proteins indicated, separated under reducing (A) or non-reducing
(B) conditions were immunoblotted using the V5 antibody to detect the exogenously expressed PDI proteins. Anti-V5 blot to detect exogenous ERp18 is shown in (C). HT1080 cells either untransfected
(UT) or stably expressing the PDI substrate-trap mutants were subjected to immunoprecipitation with the V5 antibody. Immunoisolated material was separated by SDS/PAGE and analysed by
immunoblotting with antibodies against P5 (D), PDI (E) or ERp57 (F). (R and NR indicate reducing and non-reducing SDS/PAGE conditions).
and reduces non-native disulfides or oxidized thiols [36]. Such
segregation of the pathways is achieved by the lack of disulfide
exchange between DsbA and DsbC and the inability of DsbB
and DsbD to oxidize or reduce DsbC or DsbA respectively [35].
Within the mammalian ER there does seem to be some specificity
for the oxidative pathways to oxidize specific PDI proteins but
as these can then exchange disulfides with each other, there is
no requirement for direct recycling of each PDI protein by Ero1,
PrxIV, Gpx7/8 or VKOR. Likewise, a reductive pathway would
only need to reduce ERdj5 which will then go on to reduce other
PDI proteins. Hence, a defined kinetic segregation of the two
opposing oxidative and reductive pathways does not appear to be
present within the ER of mammalian cells.
The fact that ERdj5 and ER-localized thioredoxin are mostly
oxidized would also suggest that the ER reductive pathway is
inefficient or tightly regulated to prevent excessive reduction
in the PDI proteins and to favour disulfide formation. Such a
reductive pathway may only be activated upon hyperoxidizing
conditions within the ER lumen such as occurs during the UPR
[37] or during calcium depletion [38]. Reduction in ERdj5 would
reduce the active site disulfides in other PDI proteins effectively
preventing further disulfide formation and favouring reduction in
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Figure 7 A simple model of the role of PDI oxidoreductases in oxidative folding
Oxidized PDIs, in addition to components of the ER oxidative pathways, may well supply oxidizing equivalents to other PDIs (1), allowing for introduction of disulfides into newly synthesized
substrates (2). Reduced PDIs can transfer electrons to other PDIs (3), allowing them to carry out reduction in non-native disulfides (4). Combination of steps 1–4, may operate to ensure formation of
native disulfide bonds in proteins.
non-native disulfides to allow subsequent protein folding or to
facilitate dislocation of the protein to the cytosol for degradation.
Reduction in regulatory disulfides within redox sensitive ER
resident proteins may also occur under such conditions providing
an additional layer of regulation following the UPR or oxidative
stress [20].
Whereas most of the PDI proteins tested were able to exchange
disulfides, there was some selectivity both with purified proteins
and with the substrate-trapping mutants expressed in cells. In
particular, reduced ERp72 was unable to transfer electrons to
oxidized ERp18, whereas oxidized ERp72 can be reduced by
ERp18. If the reaction was solely determined by the active site
chemistries then the reaction should proceed in both directions
until equilibrium is reached. As their calculated redox potentials
are quite similar [15,39], there must be an alternative explanation.
NMR studies have shown that the oxidized and reduced states
of ERp18 have chemical shift differences between residues in
and around the active-site disulfide, consistent with different
conformational states [40]. Hence, oxidized ERp18 may simply
form a conformation that does not interact with ERp72, which
prevents disulfide exchange.
The apparent absence of mixed disulfides formation between
some PDI proteins tested in cellulo contrasts with their ability
to exchange disulfides in vitro, for example between PDI and
ERp57 or ERp72. Demonstration of disulfide exchange with
purified proteins shows that this reaction can occur efficiently but
it does not mean that this will occur in cells where the individual
components may be in complex with other proteins precluding
their interaction. For example, ERp57 is in complex with calnexin,
calreticulin and also ERp27 [2]. Hence, the lack of mixed disulfide
formation between PDI and ERp57 indicates that ERp57 might
primarily act as a reductase and the formation of a mixed disulfide
with ERdj5 supports this conclusion.
In summary our results raise some intriguing questions about
how the balance of oxidation and reduction in disulfide bonds
is regulated in the ER lumen and suggest the absence of a clear
kinetic segregation of the pathways. Given the promiscuity of
disulfide exchange, further work needs to be carried out to identify
the mechanism for reduction in PDI proteins such as ERdj5 and
to determine how this pathway is regulated to prevent excessive
reduction in disulfides to favour disulfide formation.
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